SUSTOL- granisetron injection Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

sustol- granisetron injection

heron therapeutics, inc. - granisetron (unii: wzg3j2mcol) (granisetron - unii:wzg3j2mcol) - granisetron 10 mg in 0.4 ml - sustol is indicated in combination with other antiemetics in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (mec) or anthracycline and cyclophosphamide (ac) combination chemotherapy regimens. sustol is contraindicated in patients with hypersensitivity to granisetron, any of the components of sustol, or to any of the other 5-ht3 receptor antagonists [see warnings and precautions (5.3), description (11)] . risk summary there are no available data on the use of sustol in pregnant women. limited published data on granisetron use during pregnancy are not sufficient to inform a drug-associated risk. in animal reproduction studies, no adverse developmental effects were observed in pregnant rats and rabbits administered granisetron hydrochloride during organogenesis at intravenous doses up to 61 times and 41 times respectively the maximum recommended human dose (mrhd) of sustol 10 mg/week [see data] . the estimated b

GRANISETRON HYDROCHLORIDE injection Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

granisetron hydrochloride injection

wockhardt limited - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - - the prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. it is not known whether granisetron is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when granisetron hydrochloride injection is administered to a nursing woman. chemotherapy-induced nausea and vomiting [see dosage and administration (2)]  for use in chemotherapy-induced nausea and vomiting in pediatric patients 2 to 16 years of age. safety and effectiveness in pediatric patients under 2 years of age have not been established.

Granisetron Kabi New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

granisetron kabi

fresenius kabi new zealand limited - granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg/ml - concentrate for injection - 1 mg/ml - active: granisetron hydrochloride 1.12 mg/ml equivalent to granisetron 1 mg/ml excipient: citric acid monohydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - adults: granisetron is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy. the prevention of nausea and vomiting induced by radiotherapy. the prevention and treatment of postoperative nausea and vomiting. children: granisetron is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.

Granisetron-AFT, granisetron (as hydrochloride) 3 mg/3 mL, concentrated injection, clear type I glass ampoule Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

granisetron-aft, granisetron (as hydrochloride) 3 mg/3 ml, concentrated injection, clear type i glass ampoule

aft pharmaceuticals pty ltd - granisetron hydrochloride, quantity: 3.36 mg (equivalent: granisetron, qty 3 mg) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; nitrogen; citric acid monohydrate; sodium citrate dihydrate - granisetron injection is indicated in:,adults: - for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy - for the prevention of nausea and vomiting induced by radiotherapy,children: - for the prevention of nausea and vomiting induced by cytotoxic chemotherapy

Granisetron-AFT, granisetron (as hydrochloride) 1 mg/mL, concentrated injection, clear type I glass ampoule Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

granisetron-aft, granisetron (as hydrochloride) 1 mg/ml, concentrated injection, clear type i glass ampoule

aft pharmaceuticals pty ltd - granisetron hydrochloride, quantity: 1.12 mg (equivalent: granisetron, qty 1 mg) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; nitrogen; sodium citrate dihydrate; citric acid monohydrate - granisetron injection is indicated in:,adults: - for the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy - for the prevention of nausea and vomiting induced by radiotherapy,children: - for the prevention of nausea and vomiting induced by cytotoxic chemotherapy

Granisetron Actavis Coated Tablets 1mg Malta - Tiếng Anh - Medicines Authority

granisetron actavis coated tablets 1mg

actavis group ptc ehf - granisetron hydrochloride - coated tablet - granisetron hydrochloride 1.12 mg - antiemetics and antinauseants

Granisetron Actavis Coated Tablets 2mg Malta - Tiếng Anh - Medicines Authority

granisetron actavis coated tablets 2mg

actavis group ptc ehf - granisetron hydrochloride - coated tablet - granisetron hydrochloride 2.24 mg - antiemetics and antinauseants

Granisetron Actavis Tablet, film coated 1mg Malta - Tiếng Anh - Medicines Authority

granisetron actavis tablet, film coated 1mg

sigillata limited - granisetron hydrochloride - film-coated tablet - granisetron hydrochloride 1.12 milligram(s) - antiemetics and antinauseants

Granisetron Actavis Tablet, film coated 2mg Malta - Tiếng Anh - Medicines Authority

granisetron actavis tablet, film coated 2mg

sigillata limited - granisetron hydrochloride - film-coated tablet - granisetron hydrochloride 2.24 milligram(s) - antiemetics and antinauseants

Granisetron Sigillata 1mg film-coated Tablets Malta - Tiếng Anh - Medicines Authority

granisetron sigillata 1mg film-coated tablets

sigillata limited (ireland) inniscarra, main street, rathcoole, co. dublin d24 e029 , ireland - granisetron hydrochloride - film-coated tablet - granisetron hydrochloride 1 mg - antiemetics and antinauseants